新型染色质结构调节因子SND1促进胶质瘤增殖与侵袭并预测患者预后
研究在187例胶质瘤中分析SND1、RhoA与MKI67的表达及与预后的关系,发现SND1和RhoA为不良预后的独立预测因子,SND1通过表观遗传诱导染色质拓扑相互作用激活RhoA转录,进而调控细胞周期相关基因表达,促进胶质瘤细胞增殖与侵袭。
要点
- SND1和RhoA是胶质瘤患者不良预后的独立预测因子。
- SND1敲低显著抑制胶质瘤细胞的增殖与侵袭。
- SND1通过表观遗传诱导染色质拓扑相互作用激活RhoA转录。
核心结论
- SND1是一种新型染色质结构修饰因子,有望成为胶质瘤分类和治疗的预后指标。
- SND1和RhoA为胶质瘤患者不良预后的独立预测因子。
研究设计与样本
- 对187例胶质瘤进行SND1、RhoA和MKI67免疫染色分析。
- 采用Kaplan-Meier估计评估标志物与患者预后之间的相关性。
- 应用基因本体、染色质免疫沉淀、电泳迁移率变动分析和染色体构象捕获鉴定SND1激活的靶基因。
- 采用MTT、集落形成、Transwell和原位植入实验研究SND1在胶质瘤细胞增殖和侵袭活性中的功能。
主要发现
- SND1和RhoA为胶质瘤患者不良预后的独立预测因子。
- SND1敲低显著抑制胶质瘤细胞的增殖和侵袭。
- SND1通过表观遗传诱导染色质拓扑相互作用激活下游RhoA转录,促进恶性胶质瘤表型。
- RhoA依次调控CCND1、CCNE1、CDK4和CDKN1B的表达,加速胶质瘤细胞增殖中的G1/S期转换。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Upregulation of staphylococcal nuclease domain-containing protein 1 (SND1) is a common phenomenon in different human malignant tissues. However, little information is available on the underlying mechanisms through which SND1 affects glioma cell proliferation and invasion. METHODS: SND1, Ras homolog family member A (RhoA), and marker of proliferation Ki-67 (MKI67) were analyzed in 187 gliomas by immunostaining. The correlation between those markers and patients' prognoses was assessed using the Kaplan-Meier estimator. Gene Ontology, chromatin immunoprecipitation, electrophoretic mobility shift assay, and chromosome conformation capture were applied to identify SND1-activated target genes. We also used MTT, colony formation, transwell and orthotopic implantation assays to investigate SND1 function in glioma cell proliferative and invasive activity. RESULTS: We identified SND1 and RhoA as independent predictors of poor prognosis in glioma patients. SND1 knockdown significantly suppressed the proliferation and invasion of glioma cells. Mechanistically, we discovered that SND1 facilitated malignant glioma phenotypes by epigenetically inducing chromatin topological interaction, which activated downstream RhoA transcription. RhoA sequentially regulated expression of CCND1, CCNE1, CDK4, and CDKN1B and accelerated G1/S phase transition in glioma cell proliferation. CONCLUSIONS: Our findings identify SND1 as a novel chromatin architectural modifier and promising prognostic indicator for glioma classification and treatment.
引用
- Yu L, Xu J, Liu J, et al. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients. Neuro Oncol. 2019. PMID: 30753603. doi:10.1093/neuonc/noz038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。